In general, there is the cytoprotection concept: the described effects of the stable gastric pentadecapeptide BPC 157 (that has been found to be safe in ulcerative colitis trials, phase II, without a lethal dose (LD1) in the toxicology studies) were ascribed to its particular cytoprotective capabilities and pleiotropic background as an acting cytoprotective peptide that protects cells and may cure muscle disturbances in particular [11,12,13,14,24,25]
Barroeta I, Videla L, Carmona-Iragui M et al (2025) Current advances and unmet needs in Alzheimers disease trials for individuals with Down syndrome: navigating new therapeutic frontiers
The 60-capsule bottle provides a month-long supply for individuals who incorporate peptides into broader performance, recovery or wellness regimens
Due to its stability, BPC-157 is shown to benefit the entire GI tract with oral administration